Note 4. Accounts Receivable

Accounts receivable consisted of the following components at June 30, 2020 and 2019:


	June 30,		June 30,
(In thousands)	2020		2019
Gross accounts receivable	$	271,557	$	361,323
Less: Chargebacks reserve		(61,877)		(89,567)
Less: Rebates reserve		(24,536)		(32,099)
Less: Returns reserve		(40,796)		(55,554)
Less: Other deductions		(17,557)		(18,128)
Less: Allowance for doubtful accounts		(1,103)		(1,223)
Accounts receivable, net	$	125,688	$	164,752

For the fiscal year ended June 30, 2020, the Company recorded a provision for chargebacks, rebates, returns and other deductions of $761.8 million, $223.9 million, $16.9 million and $88.5 million, respectively. For the fiscal year ended June 30, 2019, the Company recorded a provision for chargebacks, rebates, returns and other deductions of $1.0 billion, $250.6 million, $42.0 million and $67.3 million, respectively. For the fiscal year ended June 30, 2018, the Company recorded a provision for chargebacks, rebates, returns and other deductions of $1.1 billion, $296.8 million, $24.0 million and $69.9 million, respectively.

The following table identifies the activity and ending balances of each major category of revenue-related reserve for fiscal years 2020, 2019 and 2018:


Reserve Category
(In thousands)	Chargebacks		Rebates		Returns		Other		Total
Balance at June 30, 2017	$	79,537	$	87,616	$	42,135	$	11,096	$	220,384
Current period provision		1,141,995		296,784		24,024		69,898		1,532,701
Credits issued during the period		(1,068,498)		(301,898)		(23,100)		(60,973)		(1,454,469)
Balance at June 30, 2018		153,034		82,502		43,059		20,021		298,616
Adjustment related to adoption of ASC 606		—		—		—		3,536		3,536
Current period provision		1,047,192		250,555		41,982		67,344		1,407,073
Credits issued during the period		(1,110,659)		(254,783)		(29,487)		(72,773)		(1,467,702)
Balance at June 30, 2019		89,567		78,274		55,554		18,128		241,523
Current period provision		761,787		223,932		16,863		88,468		1,091,050
Credits issued during the period		(789,477)		(239,495)		(31,621)		(89,039)		(1,149,632)
Balance at June 30, 2020	$	61,877	$	62,711	$	40,796	$	17,557	$	182,941

For the fiscal years ended June 30, 2020, 2019 and 2018, as a percentage of gross sales the provision for chargebacks was 47.2%, 51.4% and 52.0%, respectively, the provision for rebates was 13.9%, 12.3% and 13.5%, respectively, the provision for returns was 1.0%, 2.1% and 1.1%, respectively and the provision for other adjustments was 5.5%, 3.3% and 3.2%, respectively.

On July 1, 2018, the Company adopted ASC 606 which resulted in a $3.2 million pre-tax adjustment to opening retained earnings and accounts receivable, of which $3.5 million related to “failure-to-supply” reserves offset by $0.3 million related to the timing of recognition of certain contract manufacturing arrangements.

The decrease in total reserves from June 30, 2019 to June 30, 2020 was primarily attributable to a decrease in total net sales as well as product sales mix in the fiscal year ended June 30, 2020 as compared to the fiscal year ended June 30, 2019. The decrease in the chargebacks reserve was primarily due to decreases to wholesale acquisition pricing to our customers, which decrease the expected chargeback submitted by the wholesaler. The rebates reserve decreased primarily as a result of a $9.4 million rebate payment to the Department of Veteran's Affairs related to pricing overcharges, of which $8.1 million was indemnified by UCB, the former parent company of KUPI. The decrease in the returns reserve was primarily due to higher returns associated with Levothyroxine sales during the fiscal year ended June 30, 2019. Historically, we have not recorded any material amounts in the current period related to reversals or additions of prior period reserves.